Both in Pharmaceuticals
Bolt Biotherapeutics vs Skye Bioscience
Over the past year BOLT returned −31.6% and SKYE returned −94.9%; their daily moves had a correlation of 0.15.
BOLT −31.6% SKYE −94.9%Growth of $1, one year, split-adjusted
| Metric | BOLT | SKYE |
|---|---|---|
| Price | $3.60 | $1.59 |
| Market cap | $6.9M | $7.0M |
| Today | +4.04% | −1.24% |
| 1 month | −5.6% | −10.4% |
| 6 months | −15.3% | −66.5% |
| Year to date | −34.2% | −73.5% |
| 1 year | −33.6% | −95.2% |
| Revenue growth (YoY) | −99.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −154400.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | — |
| Net cash | $17.6M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 73.0% | 616.5% |
| Short % of float | 1.3% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).